PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcbnLink to Publisher's site
 
J Clin Biochem Nutr. 2010 May; 46(3): 229–233.
Published online 2010 April 10. doi:  10.3164/jcbn.09-96
PMCID: PMC2872228

Brief Questioning by Nursing Staffs before Endoscopic Examination May Not Always Pick Up Clinical Symptoms of Endoscopic Reflux Esophagitis

Abstract

The clinical features of patients reflux esophagitis without any symptoms have not been clearly demonstrated. This study evaluated the clinical features of patients with endoscopy-positive reflux esophagitis, who did not complain of symptoms, as detected by brief questioning by nursing staffs. Eight thousand and thirty-one patients not taking medication for gastrointestinal disease, were briefly asked about the presence of heartburn, dysphagia, odynophagia and acid regurgitation by nursing staffs before endoscopy for assessment of esophagitis utilizing the Los Angeles Classification. Endoscopically, 1199 (14.9%) patients were classified as positive for reflux esophagitis. The endoscope positive subjects who complain heartburn were 539/1199 (45.0%).The endoscope positive subjects who do not complain symptoms were 465 in 1199 positive reflux esophagitis (38.8%). We compared endoscopic positive subjects without any complain by brief question by nursing staffs to endoscopic positive subjects with heartburn. Male gender, no obesity, absence of hiatus hernia, and low-grade esophagitis were associated with endoscopy-positive patients who do not complain of symptoms. The results of this study indicated correct detection of clinical symptoms of reflux esophagitis might be not easy with brief questioning by nursing staffs before endoscopic examination.

Keywords: Loss Angeles Classification, gastroesophageal reflux disease, heartburn

Introduction

Gastroesophageal acid reflux causes a variety of clinical symptoms, such as heartburn, acid regurgitation, dysphagia and retrosternal pain. These reflux symptoms show varying severity, frequency and incidence [1]. Endoscopic evaluation is a reliable method for evaluation of esophagitis [1, 2] and the Los Angeles Classification is one of the most accepted grading systems for esophageal mucosal breeches [2, 3]. It is widely accepted that such typical clinical symptoms of gastroesophageal reflux reflect the presence and grading of endoscopic reflux esophagitis. Clinical symptoms might vary between countries and races [4, 5], and several studies from Japan have indicated a relationship between symptoms and reflux esophagitis [617]. Our coworkers have previously indicated that clinical symptoms detected by short questions before endoscopic examination were not always equivalent to grading of reflux esophagitis, especially regarding dysphagia, in a cross-sectional study of 8031 subjects [8, 18]. The present study aimed to assess limitation of brief asking of symptoms before endoscopic examination by nursing staffs, and to assess clinical characteristics of patients reflux esophagitis without any symptoms by this process.

Materials and Methods

Patients

This study re-analyzed, focused on symptoms detection by nursing stuff, data detected in the previous study [8], and the recruited method described briefly as follows: Patients were recruited from 23 hospitals, including the Saga Medical School, in Saga Prefecture (population, ~800,000), and were not randomly selected community samples as in our previous studies [8]. A total of 8031 Japanese patients (4120 male, 3911 female; aged >30 years, mean 59.4) were enrolled in the present multicenter study from September 1996 to October 1998. Among the 8031 patients, 6166 were outpatients who visited the 23 hospitals but did not receive medication for gastrointestinal disease, and the other 1865 were mainly selected from those receiving secondary examinations from a primary gastroenterological mass survey conducted in Saga Prefecture (50000/year), or patients who visited the hospitals for a routine physical examination. The study was conducted according to the provisions of the Declaration of Helsinki. The clinical study committee of Saga Medical School Hospital approved the study, and all patients were informed about the basic concept of the present study and of gastrointestinal endoscopy. Patients were excluded if they had received medication for gastrointestinal disease, or had had laparotomy. Patients who had had a major psychotic episode, mental retardation or dementia were also excluded.

Symptoms assessment

Before endoscopic examination, each patient was interviewed by nursing staffs who briefly asked questions regarding current clinical symptoms, including heartburn, dysphagia, odynophagia (chest pain or irritation on swallowing) and acid regurgitation. The patients simply answered “yes” or “no”. Endoscopists were blinded to the interview results before their evaluation of reflux esophagitis.

Upper gastrointestinal endoscopy

Upper gastrointestinal endoscopy for evaluation of reflux esophagitis was performed by experienced endoscopists, certified by the Japan Gastroenterological Endoscopy Society. The endoscopists were directed to grade esophageal mucosal breaks with esophagitis according to the Los Angeles Classification of Esophagitis in 1996 [2]. To reduce interobserver variation in the grading of esophagitis, pre-testing and several meetings were held before this study was conducted. The criteria for the diagnosis of esophagitis were: grade A, one or more mucosal breaks, each no longer than 5 mm; grade B, at least one mucosal break more than 5 mm long; grade C, at least one mucosal break, continuous between the tops of two or more mucosal folds; grade D, circumferential mucosal break. The endoscopists were also required to check for upper gastrointestinal diseases such as gastric and/or duodenal ulcers, polyps and cancer, but disorders other than esophagitis were not evaluated in this study.

Statistical analysis

We analyzed data from endoscopy-positive patients who did not complain of symptoms. Most of the analyses gave rise to contingency tables by the χ2 test of independence and the Cochran–Mantel–Haenzel method. We used a logistic regression model to compute the odds ratio (OR) and the 95% confidence interval (CI) in multivariate modeling. Age, sex and other symptoms were adjusted to calculate the OR. Two-tailed p values <0.05 were considered significant. Statistical analyses were performed with the SAS statistical package (version 6.08; SAS Inc., Cary, NC).

Results

Esophagitis was found in 1199/8031 (14.9%) patients. The grade of reflux esophagitis was evaluated by endoscopy, as follows: grade A, 717 (8.9%) patients; grade B, 341 (4.2%); and grade C + D, 141 (1.8%). Heartburn was the most common symptom of reflux esophagitis and was found in 539 of 1199 (45.0%) endoscopy-positive patients. Four hundred and sixty-five of 1199 (38.8%) of endoscopy-positive patients did not complain of any symptoms. The clinical characteristics of Group I (esophagitis with heartburn) and Group II (esophagitis without any symptoms) were compared. As indicated in Table 1, the number of males was significantly higher in Group II compared to Group I. Body mass index (BMI) was significantly higher in Group I than in Group II. The rate of hiatus hernia was high in Group I, and endoscopic esophagitis was significantly more severe in Group I compared to Group II. Other factors including age, smoking and alcohol consumption did not differ between the two groups.

Table 1
Analysis evaluated by χ2 test of the relationship between several factors in endoscopy-positive subjects

Univariate analysis of clinical characteristics of patients in Groups I and II is shown in Table 2. This indicated that gender, BMI, hiatus hernia, and severity of reflux were closely related to the presence or absence of clinical symptoms of endoscopic reflux esophagitis. Results of multivariate analysis are shown in Table 3. As indicated, male gender, absence of hiatus hernia, patients not overweight, and absence of severe reflux esophagitis (grades C and D) were clinical characteristics of Group II patients compared to Group I.

Table 2
Univariate analysis evaluated between Groups I and II
Table 3
Multivariate analysis evaluated between Groups I and II

Discussion

In the present study, we evaluated endoscopy-positive patients who did not complain of symptoms by brief questions by nursing staffs, as in our previous studies [8, 18], and who had not been given medication for gastrointestinal disease. Precise and structured questionnaires for reflux symptoms are useful for diagnosis of gastroesophageal reflux disease, and heartburn is a major and specific symptom that is associated with abnormal manometric and pH results [1925]. It has also been shown that a brief and simple questionnaire is reliable for noting changes in reflux symptoms [10, 26]. We did not use precise questionnaires in this study, because the aim was to establish whether patients who suffered from reflux symptoms in daily life could be detected by brief questioning by nursing staffs. This consisted of briefly asking the patients about heartburn, dysphagia, odynophagia and acid regurgitation before endoscopic examination, and the patients simply answered “yes” or “no”.

The present study focused on patients with endoscopy-positive reflux esophagitis without clinical symptoms, assessed by brief questioning by nursing staffs. The number of endoscopy-positive patients who did not complain of any symptoms was ~6% (465/8031) of the whole group tested. The ratio of patients without symptoms among those with endoscopic esophagitis was relatively high, 465/1199 (38.8%). This high ratio was partly due to the specific conditions of the present study. The patients surveyed were limited to outpatients who did not receive medication for gastrointestinal disease. The patients were selected from those receiving secondary examinations from a primary gastroenterological mass survey conducted in Saga Prefecture, and the patients visited the hospital for a routine physical examination. The level of severe esophagitis in this study was low, around 2%. The nursing staffs asked patients brief questions, and patients simply answered “yes” or “no”.

The cross-sectional study with a large subject population indicated that the characteristics of patients with endoscopic esophagitis without any clinical symptoms were male gender, absence of obesity and hiatus hernia, and low-grade esophagitis, compared to patients with endoscopic esophagitis with heartburn. We performed a large number of routine endoscopic examinations, because upper gastrointestinal endoscopy is an examination routinely performed once a year in Japan due to the high prevalence of gastric cancer and squamous cell cancer of the esophagus. As a result, the characteristics of the esophagitis patients without any symptoms questioned by nursing staffs were estimated in this study.

Endoscopic examination and clinical symptoms are most reliable for diagnosis of reflux esophagitis in normal clinical situations [1, 4, 5, 8, 2729]. This study indicated that detection of clinical symptoms of reflux esophagitis was not easy using a short questionnaire administered by nursing staffs. This suggests that precise interview for clinical symptoms and/or a questionnaire for reflux esophagitis might be required for nursing staffs and health practitioners to carry out precise diagnosis of reflux esophagitis.

References

1. DeVault K.R., Castell D.O. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol. 1999;94:1434–1442. [PubMed]
2. Armstrong D., Bennett J.R., Blum A.L., Dent J., De Dombal F.T., Galmiche J.P., Lundell L., Margulies M., Richter J.E., Spechler S.J., Tytgat G.N., Wallin L. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92. [PubMed]
3. Lundell L.R., Dent J., Bennett J.R., Blum A.L., Armstrong D., Galmiche J.P., Johnson F., Hongo M., Richter J.E., Spechler S.J., Tytgat G.N.J., Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180. [PMC free article] [PubMed]
4. Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R., the Global Consensus Group The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006;101:1900–1920. [PubMed]
5. Fock K.M., Talley N.J., Fass R., Goh K.L., Katelaris P., Hunt R., Hongo M., Ang T.L., Holtmann G., Nandurkar S., Lin S.R., Wong B.C., Chan F.K., Rani A.A., Bak Y.T., Sollano J., Ho K.Y., Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J. Gastroenterol. Hepatol. 2008;23:8–22. [PubMed]
6. Furukawa N., Iwakiri R., Koyama T., Okamoto K., Yoshida T., Kashiwagi Y., Ohyama T., Noda T., Sakata H., Fujimoto K. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J. Gastroenterol. 1999;34:441–444. [PubMed]
7. Amano K., Adachi K., Katsube T., Watanabe M., Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J. Gastroenterol. Hepatol. 2001;16:132–136. [PubMed]
8. Okamoto K., Iwakiri R., Mori M., Hara M., Oda K., Danjo A., Ootani A., Sakata H., Fujimoto K. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig. Dis. Sci. 2003;48:2237–2241. [PubMed]
9. Fujimoto K. Review article: Prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment. Pharmacol. Ther. 2004;20:5–8. [PubMed]
10. Kusano M., Shimoyama Y., Sugimoto S., Kawamura O., Maeda M., Minashi K., Kuribayashi S., Higuchi T., Zai H., Ino K., Horikoshi T., Sugiyama T., Toki M., Ohwada T., Mori M. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J. Gastroenterol. 2004;39:888–891. [PubMed]
11. Shimazu T., Matsui T., Furukawa K., Oshige K., Mitsuyasu T., Kiyomizu A., Ueki T., Yao T. A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J. Gastroenterol. 2005;40:866–872. [PubMed]
12. Mishima I., Adachi K., Arima N., Amano K., Takashima T., Moritani M., Furuta K., Kinoshita Y. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand. J. Gastroenterol. 2005;40:1005–1009. [PubMed]
13. Fujiwara Y., Higuchi K., Watanabe Y., Shiba M., Watanabe T., Tominaga K., Oshitani N., Matsumoto T., Nishikawa H., Arakawa T. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J. Gastroenterol. Hepatol. 2005;20:26–29. [PubMed]
14. Hongo M., Kinoshita Y., Shimozuma K., Kumagai Y., Sawada M., Nii M. Psychcometirc validation of the Japanese translation of the quality of life in reflux and dyspepsia questionnaire in patients with heartburn. J. Gastroenterol. 2007;42:807–815. [PubMed]
15. Miyamoto M., Haruma K., Kuwabara M., Nagano M., Okamoto T., Tanaka M. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine. J. Gastroenterol. Hepatol. 2007;22:639–644. [PubMed]
16. Joh T., Miwa H., Higuchi K., Shimatani T., Manabe N., Adachi K., Wada T., Sasaki M., Fujiwara Y., Hongo M., Chiba T., Kinoshita Y., the Acid-Related Symptom (ARS) Research Group Validity of endoscopic classification of nonerosive reflux disease. J. Gastroenterol. 2007;42:444–449. [PubMed]
17. Miwa H., Sasaki M., Furuta T., Koike T., Habu Y., Ito M., Fujiwara Y., Wada T., Nagahara A., Hongo M., Chiba T., Kinoshita Y. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment. Pharmacol. Ther. 2007;26:69–77. [PubMed]
18. Yoshihara K., Yamaguichi K., Kuroki T., Takashima T., Inoue N., Sakata H., Tsunada S., Shiraishi R., Mannen K., Fujise T., Nakayama M., Shimoda R., Iwakiri R., Fujimoto K. Dysphagia in adult Japanese is not equivalent to the grade of endoscopic reflux esophagitis. Intern. Med. 2007;46:1951–1955. [PubMed]
19. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., Riley S., Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998;33:1023–1029. [PubMed]
20. Talley N.J., Boyce P., Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998;42:690–695. [PMC free article] [PubMed]
21. Martinez-Serna T., Tercero F. Jr., Filipi C.J., Dickason T.J., Watson P., Mittal S.K., Tasset M.R. Symptom priority ranking in the care of gastroesophageal reflux: a review of 1,850 cases. Dig. Dis. 1999;17:219–224. [PubMed]
22. Haque M., Wyeth J.W., Stace N.H., Talley N.J., Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N.Z. Med. J. 2000;113:178–181. [PubMed]
23. Talley N.J., Fullerton S., Junghard O., Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am. J. Gastroenterol. 2001;96:1998–2004. [PubMed]
24. Rothman M., Farup C., Stewart W., Helbers L., Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig. Dis. Sci. 2001;46:1540–1549. [PubMed]
25. Ohara S., Kouzu T., Kawano T., Kusano M. Nationalwide epidemiological survey regarding heartburn and reflux esophagitis in Japanese. Nippon Shokakibyo Gakkai Zasshi. 2005;102:1010–1024. [PubMed]
26. Shaw M.J., Talley N.J., Beebe T.J., Rockwood T., Carlsson R., Adlis S., Fendrick A.M., Jones R., Dent J., Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am. J. Gastroenterol. 2001;96:52–57. [PubMed]
27. Adachi K., Matsumori Y., Fujisawa T., Kamada T., Kusaka M., Ohumi T., Iwakiri R., Yamaguchi K., Danjo A., Hori K., Tomita T., Hayashi T., Haruma K., Fujimoto K., Miwa H., Kinoshita Y. Symptom diversity of patients with reflux esophagitis: effect of omeprazole treatment. J. Clin. Biochem. Nutr. 2006;39:46–54.
28. Yamaguchi K., Iwakiri R., Hara M., Kikkawa A., Fujise T., Ootani H., Shimoda R., Tsunada S., Sakata H., Ushiyama O., Koarada S., Tada Y., Nagasawa K., Fujimoto K. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma. Intern. Med. 2008;47:1555–1559. [PubMed]
29. Mine S., Tanaka Y. Lansoprazole-induced improvement of esophageal submucosal injury. J. Clin. Biochem. Nutr. 2007;41:92–96. [PMC free article] [PubMed]

Articles from Journal of Clinical Biochemistry and Nutrition are provided here courtesy of The Society for Free Radical Research Japan